AstraZeneca bets $247m AI can create a cancer-fighting antibody
Startup Absci will turn to its generative AI algorithms to design synthetic protein Pharma giant AstraZeneca has signed a $247 million deal with Ai drug creation company Absci to develop an antibody designed to fight cancer....